• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三分之一的日本多发性骨软骨瘤患者可能在EXT1或EXT2以外的基因中存在突变。

One third of Japanese patients with multiple osteochondromas may have mutations in genes other than EXT1 or EXT2.

作者信息

Kojima Hirofumi, Wada Takahito, Seki Hiroshi, Kubota Takeo, Wakui Keiko, Fukushima Yoshimitsu

机构信息

Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Genet Test. 2008 Dec;12(4):557-61. doi: 10.1089/gte.2008.0048.

DOI:10.1089/gte.2008.0048
PMID:18976157
Abstract

Multiple osteochondromas (MO; also referred to as hereditary multiple exostoses [HME] in the literature) is an autosomal dominant disorder characterized by benign, cartilage-capped bone tumors that grow from the metaphyses of long bones. Two genes are associated with this disease: EXT1 on 8q24.11-q24.13 and EXT2 on 11p12-p11. Mutations in EXT1 and EXT2 are found in 54-96% of patients with MO and are generally more frequent in EXT1 than in EXT2. We previously studied 43 Japanese families with MO using single-strand conformation polymorphism analysis for EXT1 and EXT2, and reported 23 families (54%) with mutations and 20 families (46%) with no mutations in these genes. Among the families with mutations, 17 families (40%) had mutations in EXT1, and 6 families (14%) had mutations in EXT2. Here we examined the same 43 Japanese families using denaturing high-performance liquid chromatography as an alternative technique. We detected five mutations, three of which are novel, in seven families in addition to the previously described mutations. In summary, we detected mutations in EXT1 or EXT2 in 30 (70%) out of 43 families. Our result suggests the presence of other gene(s) responsible for MO, at least in Japanese patients.

摘要

多发性骨软骨瘤(MO;在文献中也称为遗传性多发性骨疣 [HME])是一种常染色体显性疾病,其特征为从长骨干骺端长出的良性、有软骨帽的骨肿瘤。有两个基因与该疾病相关:位于8q24.11 - q24.13的EXT1和位于11p12 - p11的EXT2。在54% - 96%的MO患者中发现EXT1和EXT2的突变,且EXT1的突变通常比EXT2更常见。我们之前对43个日本MO家系进行了研究,采用单链构象多态性分析检测EXT1和EXT2,报告了23个家系(54%)这些基因有突变,20个家系(46%)无突变。在有突变的家系中,17个家系(40%)EXT1有突变,6个家系(14%)EXT2有突变。在此,我们使用变性高效液相色谱作为替代技术对相同的43个日本家系进行检测。除了先前描述的突变外,我们在7个家系中检测到5个突变,其中3个是新突变。总之,我们在43个家系中的30个(70%)检测到EXT1或EXT2的突变。我们的结果表明,至少在日本患者中,存在其他与MO相关的基因。

相似文献

1
One third of Japanese patients with multiple osteochondromas may have mutations in genes other than EXT1 or EXT2.三分之一的日本多发性骨软骨瘤患者可能在EXT1或EXT2以外的基因中存在突变。
Genet Test. 2008 Dec;12(4):557-61. doi: 10.1089/gte.2008.0048.
2
Large-scale mutational analysis in the EXT1 and EXT2 genes for Japanese patients with multiple osteochondromas.对日本多发性骨软骨瘤患者的EXT1和EXT2基因进行大规模突变分析。
BMC Genet. 2016 Mar 9;17:52. doi: 10.1186/s12863-016-0359-4.
3
Mutation screening for the EXT1 and EXT2 genes in Chinese patients with multiple osteochondromas.对多发性骨软骨瘤中国患者的 EXT1 和 EXT2 基因进行突变筛查。
Arch Med Res. 2013 Oct;44(7):542-8. doi: 10.1016/j.arcmed.2013.09.008. Epub 2013 Oct 10.
4
An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.一种用于遗传性多发性骨软骨瘤中EXT1和EXT2基因分子检测的优化变性高效液相色谱法方案。
Clin Genet. 2005 Dec;68(6):542-7. doi: 10.1111/j.1399-0004.2005.00538.x.
5
Identification of Novel Mutations in the and Genes of Chinese Patients with Hereditary Multiple Osteochondromas.鉴定中国遗传性多发性骨软骨瘤患者 和 基因中的新型突变。
Genet Test Mol Biomarkers. 2021 Feb;25(2):145-151. doi: 10.1089/gtmb.2020.0098.
6
Mutation spectrum of EXT1 and EXT2 in the Saudi patients with hereditary multiple exostoses.EXT1 和 EXT2 基因突变谱在沙特遗传性多发性外生骨疣患者中的研究。
Orphanet J Rare Dis. 2021 Feb 25;16(1):100. doi: 10.1186/s13023-021-01738-z.
7
Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.台湾多发性外生骨疣患者中的三种新型EXT1和EXT2基因突变。
J Formos Med Assoc. 2006 May;105(5):434-7. doi: 10.1016/s0929-6646(09)60143-1.
8
Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.通过变性高效液相色谱法(DHPLC)在意大利多发性骨软骨瘤患者中鉴定出的新型EXT1和EXT2突变。
Hum Mutat. 2005 Sep;26(3):280. doi: 10.1002/humu.9359.
9
Novel and recurrent mutations in the EXT1 and EXT2 genes in Chinese kindreds with multiple osteochondromas.EXT1 和 EXT2 基因中新发和频发突变与中国人多发性骨软骨瘤家系相关。
J Orthop Res. 2013 Sep;31(9):1492-9. doi: 10.1002/jor.22378. Epub 2013 Apr 29.
10
Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses.对波兰遗传性多发性骨软骨瘤患者的EXT1和EXT2基因进行突变筛查。
J Appl Genet. 2014 May;55(2):183-8. doi: 10.1007/s13353-014-0195-z. Epub 2014 Feb 15.

引用本文的文献

1
Whole‑exome sequencing identifies a novel mutation of SLC20A2 (c.C1849T) as a possible cause of hereditary multiple exostoses in a Chinese family.全外显子测序鉴定出 SLC20A2 中的一个新突变(c.C1849T)可能是一个中国家族遗传性多发性外生骨疣的致病原因。
Mol Med Rep. 2020 Sep;22(3):2469-2477. doi: 10.3892/mmr.2020.11298. Epub 2020 Jul 6.